KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Receivables: 2010-2021

Historic Receivables for TherapeuticsMD (TXMD) over the last 12 years, with Dec 2021 value amounting to $36.2 million.

  • TherapeuticsMD's Receivables fell 14.02% to $32.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $149.6 million, marking a year-over-year increase of 9.17%. This contributed to the annual value of $36.2 million for FY2021, which is 11.72% up from last year.
  • According to the latest figures from FY2021, TherapeuticsMD's Receivables is $36.2 million, which was up 11.72% from $32.4 million recorded in FY2020.
  • Over the past 5 years, TherapeuticsMD's Receivables peaked at $36.2 million during FY2021, and registered a low of $4.3 million during FY2017.
  • In the last 3 years, TherapeuticsMD's Receivables had a median value of $32.4 million in 2020 and averaged $31.0 million.
  • Its Receivables has fluctuated over the past 5 years, first dropped by 3.82% in 2017, then soared by 155.59% in 2018.
  • Yearly analysis of 5 years shows TherapeuticsMD's Receivables stood at $4.3 million in 2017, then spiked by 155.59% to $11.1 million in 2018, then spiked by 120.50% to $24.4 million in 2019, then surged by 32.74% to $32.4 million in 2020, then rose by 11.72% to $36.2 million in 2021.